Cover Story

Metabolic Breakthrough

By Eric Seaborg, PhD

Hormone fibroblast growth factor 21 holds promise for treating diabetes, obesity, and metabolic syndrome, but new drug treatments remain years away

Read More

Features

• HOPE for Adrenal Cancer

  By John Bohannon, PhD
  Despite some disappointing studies, researchers pursue IGF2 and other suspects for drug targets

  Read More

• Hypertension ESAP Case

  HYPERTENSION MYSTERY: A Case Study From ESAP™ A45-year-old woman presents with a nine-year history of hypertension. Her current antihypertensive medications include amlodipine, 10 mg dai...

  Read More

• Flexing MUSSELS

  By Melissa Mapes
  Glue secreted by these bivalves could prove effective in treatments for numerous cardiovascular diseases

  Read More

• The 38,460 MENACE

  By Kelly Horvath
  Deadly pancreatic cancer demands resourceful treatment approach

  Read More